United States · Venture startup

Who invested in Invenio Imaging

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2023, from 1 source

Latest round
VentureJun 2023
Investors
3
See who backed them

The rounds

  1. Jun 2023
    VentureAmount undisclosed

    Source recorded

Founders and team

From the SEC filings it signed: 1 on the team.

  • Jay TrautmanExecutive Officer, Directori

On the board, as filediChristian FreudigerDouglas CrawfordMichael Ming-Yih Wu

Everyone who backed them

MedTech InnovatorAccelerator1round
Catalyst FundGrowth equity1round
Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Invenio Imaging as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Mission Bay CapitalVC firmPer its own site

Quick answers about Invenio Imaging

Who invested in Invenio Imaging?

Invenio Imaging's investors include MedTech Innovator, Catalyst Fund and Mission BioCapital.

How much has Invenio Imaging raised?

Invenio Imaging has raised 1 round since 2023, none with a disclosed amount.

When did Invenio Imaging last raise?

Invenio Imaging's most recent round was a Venture in Jun 2023.

Who backed Invenio Imaging first?

Invenio Imaging's first round on record, in Jun 2023, was backed by MedTech Innovator, Catalyst Fund and Mission BioCapital.

What stage is Invenio Imaging at?

Invenio Imaging's latest named round is a Venture, in Jun 2023.

Where is Invenio Imaging based?

Invenio Imaging is based in the United States.

Companies like Invenio Imaging

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.